Eurofins-Cerep SA Total Assets

Latest as of December 2025: €88.84 Million EUR ≈ $103.86 Million USD

Eurofins-Cerep SA total assets. Based on the latest financial reports, Eurofins-Cerep SA (ALECR) holds total assets worth €88.84 Million EUR (≈ $103.86 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Eurofins-Cerep SA (ALECR) total market value for the company's overall valuation and market capitalisation.

Total Assets of Eurofins-Cerep SA (2000–2025)

Total assets of Eurofins-Cerep SA from 2000 to 2025. This chart illustrates how Eurofins-Cerep SA's total assets have evolved over time, based on quarterly financial data. See current stock price of Eurofins-Cerep SA for real-time trading data and today's change.

Eurofins-Cerep SA - Asset Composition Analysis

Eurofins-Cerep SA Total Assets Breakdown (December 2025)

Eurofins-Cerep SA total assets breakdown as of December 2025. Eurofins-Cerep SA's total assets of €88.84 Million consist of 89.4% current assets and 10.6% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 10.3%
Accounts Receivable €55.28 Million 62.2%
Inventory €2.54 Million 2.9%
Property, Plant & Equipment €0.00 0.0%
Intangible Assets €77.35K 0.1%
Goodwill €2.23 Million 2.5%

Asset Composition Trend (2000–2025)

This chart illustrates how Eurofins-Cerep SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Eurofins-Cerep SA to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Eurofins-Cerep SA's current assets represent 89.4% of total assets in 2025, an increase from 0.0% in 2000.
  • Cash Position: Cash and equivalents constituted 10.3% of total assets in 2025, up from 8.1% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2000.
  • Asset Diversification: The largest asset category is accounts receivable at 62.2% of total assets.

Eurofins-Cerep SA Competitors by Total Assets

Key competitors of Eurofins-Cerep SA based on total assets are shown below.

Company Country Total Assets
Lonza Group AG
SW:LONN
Switzerland CHF18.26 Billion
Revvity Inc.
NYSE:RVTY
USA $12.00 Billion
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB
India Rs31.46 Billion
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
China CN¥9.20 Billion
Cowealth Medical China Co.Ltd.
SHG:603122
China CN¥1.42 Billion
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Prodia Widyahusada Tbk PT
JK:PRDA
Indonesia Rp2.57 Trillion
Scope Fluidics SA
WAR:SCP
Poland zł141.67 Million

Eurofins-Cerep SA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 7.83 6.94 4.47
Quick Ratio 7.58 6.62 4.25
Cash Ratio 0.00 0.00 0.00
Working Capital €69.27 Million €62.18 Million €29.19 Million

Eurofins-Cerep SA - Advanced Valuation Insights

This section examines the relationship between Eurofins-Cerep SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.20
Latest Market Cap to Assets Ratio 1.03
Asset Growth Rate (YoY) 5.7%
Total Assets €88.84 Million
Market Capitalization $91.80 Million USD

Valuation Analysis

Above Book Valuation: The market values Eurofins-Cerep SA's assets above their book value (1.03x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Eurofins-Cerep SA's assets grew by 5.7% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Eurofins-Cerep SA (2000–2025)

The table below shows the annual total assets of Eurofins-Cerep SA from 2000 to 2025.

Year Total Assets Change
2025-12-31 €88.84 Million
≈ $103.86 Million
+5.68%
2024-12-31 €84.06 Million
≈ $98.28 Million
+6.07%
2023-12-31 €79.25 Million
≈ $92.65 Million
+11.54%
2022-12-31 €71.05 Million
≈ $83.06 Million
+18.95%
2021-12-31 €59.73 Million
≈ $69.83 Million
+29.67%
2020-12-31 €46.06 Million
≈ $53.85 Million
+15.30%
2019-12-31 €39.95 Million
≈ $46.71 Million
+13.31%
2018-12-31 €35.26 Million
≈ $41.22 Million
+16.83%
2017-12-31 €30.18 Million
≈ $35.28 Million
+16.33%
2016-12-31 €25.94 Million
≈ $30.33 Million
+3.02%
2015-12-31 €25.18 Million
≈ $29.44 Million
+9.97%
2014-12-31 €22.90 Million
≈ $26.77 Million
-17.89%
2013-12-31 €27.89 Million
≈ $32.60 Million
-7.92%
2012-12-31 €30.28 Million
≈ $35.40 Million
-7.45%
2011-12-31 €32.72 Million
≈ $38.26 Million
-8.84%
2010-12-31 €35.90 Million
≈ $41.97 Million
-18.98%
2009-12-31 €44.31 Million
≈ $51.80 Million
-19.30%
2008-12-31 €54.91 Million
≈ $64.19 Million
-12.47%
2007-12-31 €62.73 Million
≈ $73.34 Million
-17.86%
2006-12-31 €76.37 Million
≈ $89.29 Million
-8.70%
2005-12-31 €83.65 Million
≈ $97.79 Million
+30.95%
2004-12-31 €63.87 Million
≈ $74.68 Million
+24.65%
2003-12-31 €51.24 Million
≈ $59.91 Million
+7.39%
2002-12-31 €47.72 Million
≈ $55.78 Million
+16.67%
2001-12-31 €40.90 Million
≈ $47.81 Million
+72.80%
2000-12-31 €23.67 Million
≈ $27.67 Million
--

About Eurofins-Cerep SA

PA:ALECR France Diagnostics & Research
Market Cap
$108.50 Million
€92.81 Million EUR
Market Cap Rank
#19342 Global
#288 in France
Share Price
€18400.00
Change (1 day)
+0.00%
52-Week Range
€15000.00 - €18600.00
All Time High
€18600.00
About

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound management, and high-throughout screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was foun… Read more